A bactericidal tuberculosis drug regimen driven by inhibition of the terminal oxidases by pretomanid
- DOI
- 10.1038/s44321-026-00378-9
- Published
- 2026-02-06
- Container
- EMBO Molecular Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s44321-026-00378-9,
title = {A bactericidal tuberculosis drug regimen driven by inhibition of the terminal oxidases by pretomanid},
author = {Nurlilah Ab Rahman and Samsher Singh and Thomas Wiggins and May Delos Santos and Garrett C Moraski and Marvin J Miller and Michael Berney and Kevin Pethe},
year = {2026},
journal = {EMBO Molecular Medicine},
doi = {10.1038/s44321-026-00378-9},
url = {https://doi.org/10.1038/s44321-026-00378-9}
}RIS
TY - JOUR TI - A bactericidal tuberculosis drug regimen driven by inhibition of the terminal oxidases by pretomanid AU - Nurlilah Ab Rahman AU - Samsher Singh AU - Thomas Wiggins AU - May Delos Santos AU - Garrett C Moraski AU - Marvin J Miller AU - Michael Berney AU - Kevin Pethe PY - 2026 JO - EMBO Molecular Medicine DO - 10.1038/s44321-026-00378-9 UR - https://doi.org/10.1038/s44321-026-00378-9 ER -
APA
Rahman, N. A., Singh, S., Wiggins, T., Santos, M. D., Moraski, G. C., Miller, M. J., Berney, M., & Pethe, K. (2026). A bactericidal tuberculosis drug regimen driven by inhibition of the terminal oxidases by pretomanid. EMBO Molecular Medicine. https://doi.org/10.1038/s44321-026-00378-9
Source records
- crossref · retrieved 2026-09-27T08:16:11.979Z